WKN: | 898321 |
ISIN: | AU000000COH5 |
Land: | Australien |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Medizintechnik |
Weshalb die Cochlear-Aktie
ein A-Rating hat,
erfahren Sie im Performance-Check
vom 28. Juli 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2005 | 14,37 | 28,50 | 98,33% |
2 | 2009 | 26,13 | 42,08 | 61,04% |
3 | 2010 | 42,08 | 62,47 | 48,46% |
4 | 2023 | 129,48 | 183,52 | 41,74% |
5 | 2014 | 38,10 | 51,68 | 35,64% |
6 | 2017 | 83,51 | 111,24 | 33,21% |
7 | 2019 | 106,82 | 142,00 | 32,93% |
8 | 2016 | 63,77 | 83,51 | 30,96% |
9 | 2012 | 48,40 | 62,05 | 28,20% |
10 | 2007 | 34,44 | 43,28 | 25,67% |
11 | 2015 | 51,68 | 63,77 | 23,39% |
12 | 2001 | 21,70 | 26,50 | 22,12% |
13 | 2006 | 28,50 | 34,44 | 20,84% |
14 | 2021 | 119,48 | 139,80 | 17,01% |
15 | 2004 | 13,00 | 14,37 | 10,54% |
16 | 2025 | 176,50 | 175,42 | -0,61% |
17 | 2024 | 183,52 | 176,50 | -3,83% |
18 | 2018 | 111,24 | 106,82 | -3,97% |
19 | 2022 | 139,80 | 129,48 | -7,38% |
20 | 2020 | 142,00 | 119,48 | -15,86% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2008 | 43,28 | 26,13 | -39,63% |
2 | 2013 | 62,05 | 38,10 | -38,60% |
3 | 2003 | 20,50 | 13,00 | -36,59% |
4 | 2002 | 26,50 | 20,50 | -22,64% |
5 | 2011 | 62,47 | 48,40 | -22,52% |
6 | 2020 | 142,00 | 119,48 | -15,86% |
7 | 2022 | 139,80 | 129,48 | -7,38% |
8 | 2018 | 111,24 | 106,82 | -3,97% |
9 | 2024 | 183,52 | 176,50 | -3,83% |
10 | 2025 | 176,50 | 175,42 | -0,61% |
11 | 2004 | 13,00 | 14,37 | 10,54% |
12 | 2021 | 119,48 | 139,80 | 17,01% |
13 | 2006 | 28,50 | 34,44 | 20,84% |
14 | 2001 | 21,70 | 26,50 | 22,12% |
15 | 2015 | 51,68 | 63,77 | 23,39% |
16 | 2007 | 34,44 | 43,28 | 25,67% |
17 | 2012 | 48,40 | 62,05 | 28,20% |
18 | 2016 | 63,77 | 83,51 | 30,96% |
19 | 2019 | 106,82 | 142,00 | 32,93% |
20 | 2017 | 83,51 | 111,24 | 33,21% |